Singapore SWF Temasek to Buy 3.6% of Bayer for $3.6 Billion
The Sovereign Wealth Fund of Singapore Temasek Holdings with $208 billion managed assets, has agreed to buy 3.6% of German life science company Bayer for $3.6 Billion (Euro 3 Billion). The German company is currently preparing the final stages of their $66 billion acquisition of leading global seed producer Monsanto. Temasek will subscribe to 31 million new shares (3.6%) of Bayer, giving it about 4% shareholding, including existing shares.
” Singapore SWF Temasek to Buy 3.6% of Bayer for $3.6 Billion “
Bayer is a global life science enterprise in the field of health care and agriculture, employing almost 100,00 people worldwide and generating Euro 35 billion in sales in 2017. In recent years, there has been major consolidations in the industry with the $130 billion merger of Dow Chemical Co. and DuPont Co, and China National Chemical Corporation (ChemChina) $43 billion acquisition of Syngenta AG.
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of 35.0 billion euros. Capital expenditures amounted to 2.4 billion euros, R&D expenses to 4.5 billion euros.
The Wealth Insider is the world’s leading wealth intelligence for global wealth managers, investments managers, asset managers, high net-worth service providers and wealthy individuals. Our global workforce seamlessly present the inside news of the most relevant news, insights, global wealth trends, innovation & digital transformation to our global audience.
Get The Wealth Insider Daily
- For Press Release, please contact firstname.lastname@example.org
- For Media-related enquiries, please contact email@example.com
- For Advertisement, please contact our official ad agency